Pharmaceutical industry
The US economy continued to slide into a deep recession, with several major corporations announcing mass layoffs to cut costs and survive the downturn. The cuts affected a total of 45,000 jobs, including 20,000 at Caterpillar, 8,000 at Sprint Nextel, and 7,000 at Home Depot. President
Pharmaceutical industry
A small biotech firm, Elusys Therapeutics Inc., has collaborated with Pfizer, the world's largest pharmaceutical company, to create medicines that tackle life-threatening infections. The partnership aims to develop an experimental drug to counteract drug-resistant staph cases, starting with methicillin-resistant Staphylococcus aureus (MRSA) infections. MRSA is a highly contagious
Pharmaceutical industry
In 2006, the U.S. regulatory agency approved 18 new drugs, marking a significant decline from the annual average of 26 recorded in the previous six years. This trend is attributed to the pharmaceutical industry's focus on complex diseases that are harder to treat, resulting in a higher
Pharmaceutical industry
Pfizer's highly anticipated cholesterol pill, torcetrapib, has been pulled from clinical trials after an independent monitor found heart problems and a higher number of deaths among patients taking a combination of the drug and Pfizer's popular Lipitor. This decision has left cardiologists and patients disappointed, as
Pharmaceutical industry
Pfizer's decision to scrap its experimental cholesterol drug torcetrapib, which was set to play a key role in the company's cholesterol franchise, has thrown the competitive dynamics in the lucrative cholesterol drug market into flux. The surprise end for torcetrapib due to deaths and cardiac events
Pharmaceutical industry
AstraZeneca's Crestor and Pfizer's Lipitor topped the list of most-promoted products to key managed care pharmacy executives in the third quarter of 2006, according to the Cognet-X PAR-Rx Report. The two brands stood strong against market share intrusion from new generic statins, with Crestor and Lipitor
Pharmaceutical industry
Schaeffer's Today's Market, a free market commentary written by Schaeffer's financial analysts and traders, highlighted key market trends on November 30. The commentary covered various stocks, including Microsoft (MSFT), Wal-Mart Stores (WMT), Pfizer (PFE), General Motors (GM), and Limited (LTD). The article also discussed
Pharmaceutical industry
This year in the United States, breast cancer will claim the lives of approximately 40,970 women, while 212,920 women and 1,720 men will be diagnosed with invasive breast cancer. A recent landmark clinical trial has given new hope for breast cancer survival with Pfizer's AROMASIN,
Pharmaceutical industry
The merger and acquisition market has seen a significant surge in activity, with major deals announced in recent days. Phelps Dodge, a US copper giant, has offered $37.7 billion for Canadian nickel miners Inco and Falconbridge, while Johnson & Johnson will buy Pfizer's consumer health brands for
Pharmaceutical industry
The December 19 edition of Schaeffer's S&P 500 Index Hot Stocks highlights various stocks, including Pfizer, Tektronix, and Circuit City Stores, which have seen significant price movements due to various company-specific news and market factors. Despite the major market indices being mixed, the S&P
Pharmaceutical industry
Pfizer, a pharmaceutical giant, has been dealt a significant victory in a patent case involving its statin medication Lipitor. A court ruling in its favor has sent the company's stock soaring, increasing by 25 percent, including late Friday trading. This development comes as a welcome respite for Pfizer,
Pharmaceutical industry
The 7th U.S. Circuit Court of Appeals has issued two recent decisions, Pfizer Inc. vs. Lott and Schorsch vs. Hewlett-Packard Co., clarifying the application of the Class Action Fairness Act of 2005 (CAFA) to class actions filed before its enactment. The court has made it clear that "commenced,
